億都(國際控股)(00259.HK)盈警:預期年度擁有人應占溢利約1.95億港元
格隆匯5月31日丨億都(國際控股)(00259.HK)公吿,公司預期截至2024年3月31日止年度的公司擁有人應占溢利錄得約1.95億港元,而去年則錄得6.15億港元。
董事會相信,上述減少主要由於以下因素:(i)去年錄得出售集團於集團聯營公司南通江海電容器股份有限公司的部分股權的非經常性收益約2.11億港元;(ii)去年錄得因集團聯營公司蘇州清越光電科技股份有限公司股份上市被視為出售的非經常性收益約1.48億港元;(iii)分佔聯營公司業績減少;及(iv)來自顯示器業務的收入下跌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.